2020 has been marked by the SARS-CoV-2 pandemic, which has wreaked havoc worldwide and has demonstrated, once and for all, the importance of research.
The virology and immune system expertise accumulated in IrsiCaixa over 25 years has enabled it to rapidly launch SARS-CoV-2 research projects and brought it to the forefront of the fight against the virus. Its projects focus on different aspects of the coronavirus, including prevention, detection and treatment.
The response has been deliberately rapid and collaborative in order to be able to deliver results in the shortest possible time. IrsiCaixa is currently cooperating with other institutions to develop a coronavirus vaccine and drugs and is participating in different clinical trials to reduce transmission and treat the progression of the disease.
We share in open access and real time the results of our experiments publishing them in open access respositories and scientific journals, in order to provide rapid and updated information for the design of clinical trials.
This page brings together all information regarding our coronavirus research.
During the pandemic, sharing knowledge with the scientific community has been key to accelerate research. Here you can find all the publications of the studies carried out at IrsiCaixa in the field of COVID-19.
IrsiCaixa is leading research projects on the SARS-CoV-2 coronavirus. We introduce you to the researchers racing against time to fight COVID-19.
